Cookies on Dublin People website
We use cookies to ensure that we give you the best experience on our website. We also use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on the Dublin People website. However, if you would like to, you can change your cookie settings at any time by amending your browser settings.
How does Dublin People use cookies?
Cookies enable us to identify your device, or you when you have logged in. We use cookies that are strictly necessary to enable you to move around the site or to provide certain basic features. We use cookies to enhance the functionality of the website by storing your preferences, for example. We also use cookies to help us to improve the performance of our website to provide you with a better user experience.
We dont sell the information collected by cookies, nor do we disclose the information to third parties, except where required by law (for example to government bodies and law enforcement agencies).
Hide Message
  • Southside

UCD expansion to help new start-up companies

Tuesday, 23rd October, 2018 7:59am
UCD expansion to help new start-up companies

Pictured at NovaUCD is Tom Flanagan, Director of Enterprise and Commercialisation at University College Dublin.

UCD expansion to help new start-up companies

Pictured at NovaUCD is Tom Flanagan, Director of Enterprise and Commercialisation at University College Dublin.

A development project at UCD will help expand the college’s start-up business programme for new ventures and entrepreneurs by over 50 percent, it has been revealed.

NovaUCD is set to expand its capacity to house early-stage start-ups after the project to renovate and extend the facility’s east courtyard got underway recently. It is expected to be completed within 12 months.

NovaUCD, based on UCD’s Belfield campus, officially opened in October 2003 and is currently home to over 25 start-up companies. These companies have either spun-out of UCD research programmes or have spun-in to locate at NovaUCD in order to collaborate with the university.

Since opening, the hub has supported some 225 companies, which have raised over €200 million in equity funding to develop and grow. As the home of UCD’s technology transfer team, NovaUCD has also registered some 750 invention disclosures, filed over 250 priority patent applications and licenced over 170 technologies to companies such as Amdocs, Amryt and Glanbia. 

Tom Flanagan, UCD’s Director of Enterprise and Commercialisation, said the NovaUCD facility had been running at full capacity for several years now.

“There is an ongoing and significant demand from ambitious entrepreneurs who want to locate their start-ups at NovaUCD to leverage our ecosystem of experienced mentors, founders, alumni, investors and sponsors who can help them grow their businesses globally,” Mr Flanagan said. 

“By joining the NovaUCD community, these start-ups can also take advantage of access to our world-class researchers, facilities and talent across the UCD campus.

“The development of the east courtyard will enable us to increase our capacity by over 50 percent and when completed NovaUCD will be able to accommodate up to 450 people.” 

NovaUCD is located in a mid-18th century house, formerly known as Merville House. It currently comprises a restored main building along with the restoration and extension of the west courtyard. The current expansion will see the renovation and extension of a second, or east, courtyard.

NovaUCD currently has 1,425m2 of space in a total of 40 units, labs and co-working space. The newly developed courtyard will result in 800m2 of additional licensable space, and will include a total of 23 business units, labs and co-working space. 

The internal courtyard area will be designed as a new meeting and social space for client companies.

Some of the best-known start-ups supported by NovaUCD include spin-out companies, ChangingWorlds, BiancaMed, Equinome and Logentries and spin-in companies, EnBIO and Genomics Medicine Ireland. 

Among the companies currently located at NovaUCD are Carrick Therapeutics, OncoMark and THEYA Healthcare.

Six private sector sponsors, including AIB, Arthur Cox, Deloitte, Ericsson, Goodbody Stockbrokers and Xilinx, contributed 75 percent of the €10 million raised to develop the first two phases of NovaUCD, with the balance of funds provided by Enterprise Ireland and UCD.

The architects for this current project are Kavanagh Tuite Architects, who were architects for the original design of the NovaUCD facility.

Read the digital editions of the Dublin People Northside East, Northside West & Southside here